No Data
ATB Cormark Capital Markets Maintains OrganiGram(OGI.US) With Buy Rating, Cuts Target Price to $1.82
Analysts Offer Insights on Healthcare Companies: Organigram Global (OGI) and NeuroOne Medical Technologies (NMTC)
Haywood Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.37
A. G. P. Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.92
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Tvardi Therapeutics (TVRD) and Organigram Global (OGI)
Earnings Call Summary | Organigram Global Inc(OGI.CA) Q2 2026 Earnings Conference